Biotechnology Stocks I Performance Guide: ImmunityBio, Inc. (IBRX)
IBRX has no dividends.
Table and Chart of IBRX Performance
See what a $1,000 investment in IBRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| IBRX Returns | |
|---|---|
| Start Date | Aug-31-2015 |
| Start Price | $17.12 |
| End Date | Jul-26-2024 |
| End Price | $5.61 |
| # Prices | 108 |
| Min Date | Jun-28-2019 |
| Min Price | $1.02 |
| Max Date | Feb-26-2021 |
| Max Price | $32.51 |
| Total Return | -67.23% |
| Annualized Return | -11.66% |
| Current Value of $1,000 Purchase | $328 |
| Number Returns | 5,778 |
| Average Return | 65.53% |
| Number Profitable Returns | 2,434 |
| Percent Profitable Returns | 42.13% |
| Number Unprofitable Returns | 3,344 |
| Percent Unprofitable Returns | 57.87% |
| Profitable to Unprofitable Returns Ratio | 0.73 |
| IBRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,952,311,000 |
| Beta | -0.307 | Price to Sales | 13,075.67 |
| Earnings per Share | $-1.0800 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $10.53 |
| 52 Week Low | $1.25 |
| Analyst Target Price | $7.5 |
| 50-Day Moving Average | $6.47 |
| 200-Day Moving Average | $4.965 |
| FINANCIAL DATA | |
| Revenue per Share | $0.001 |
| Revenue | $302,000 |
| Profit Margin | 0% |
| Return on Equity | 0% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
IBRX Compare Returns with S&P 500
IBRX Trendline Chart
IBRX Moving Average Chart
IBRX Stock Return Map - See Patterns of Gains and Losses
IBRX Stock Returns/Purchase Dates